Aprea Therapeutics (APRE) Institutional Ownership $1.85 +0.04 (+2.20%) Closing price 05/2/2025 03:58 PM EasternExtended Trading$1.82 -0.03 (-1.62%) As of 05/2/2025 05:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Aprea Therapeutics (NASDAQ:APRE)CurrentInstitutional OwnershipPercentage34.19%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$854.84KNumber ofInstitutional Sellers(last 12 months)0 Get APRE Insider Trade Alerts Want to know when executives and insiders are buying or selling Aprea Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data APRE Institutional Buying and Selling by Quarter Aprea Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025Stonepine Capital Management LLC149,221$491K0.4%+8.8%2.748% 2/17/2025BNP Paribas Financial Markets13,011$43K0.0%N/A0.240% 2/12/2025Landscape Capital Management L.L.C.35,328$116K0.0%N/A0.651% 2/11/2025LPL Financial LLC16,052$53K0.0%N/A0.296% 8/21/2024Stonepine Capital Management LLC137,174$558K0.5%N/A2.526% 8/9/2024Dimensional Fund Advisors LP11,071$45K0.0%N/A0.204% 5/15/2023AIGH Capital Management LLC345,000$1.53M0.6%N/A9.244% 5/15/2023Sio Capital Management LLC280,000$1.24M0.6%N/A7.503% 5/12/2022Gyon Technologies Capital Management LP20,570$38K0.0%N/A0.094% 5/12/2022 Magnus Financial Group LLC14,856$28K0.0%-56.3%0.068% Get the Latest News and Ratings for APRE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aprea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/2022Kennedy Capital Management Inc.336,730$966K0.0%-1.7%1.569% 2/14/2022PDT Partners LLC142,600$409K0.0%+62.5%0.664% 2/10/2022 Magnus Financial Group LLC33,981$98K0.0%N/A0.158% 11/16/2021Verition Fund Management LLC20,101$103K0.0%N/A0.094% 11/12/2021Geode Capital Management LLC198,339$1.01M0.0%+89.9%0.936% 11/10/2021Goldman Sachs Group Inc.144,758$740K0.0%+131.4%0.683% 11/9/2021BlackRock Inc.354,275$1.81M0.0%-0.9%1.672% 9/17/2021Virtu Financial LLC41,142$201K0.0%+292.9%0.194% 8/17/2021Walleye Capital LLC98,931$483K0.0%-16.5%0.467% 8/17/2021Walleye Trading LLC27,455$134K0.0%-33.4%0.130% 8/16/2021PDT Partners LLC124,234$606K0.0%N/A0.586% 8/16/2021Morgan Stanley1,019,776$4.98M0.0%+2.2%4.813% 8/16/2021Kennedy Capital Management Inc.353,926$1.73M0.0%+575.2%1.670% 8/16/2021Charles Schwab Investment Management Inc.50,366$246K0.0%-26.5%0.238% 8/16/2021State Street Corp40,832$199K0.0%-67.2%0.193% 8/16/2021Goldman Sachs Group Inc.62,546$305K0.0%-14.4%0.295% 8/13/2021Northern Trust Corp32,530$159K0.0%-69.2%0.154% 8/13/2021Geode Capital Management LLC104,447$509K0.0%-35.2%0.493% 8/13/2021Vanguard Group Inc.707,422$3.45M0.0%-6.0%3.339% 8/12/2021 SG Americas Securities LLC598,395$2.92M0.0%-8.8%2.824% 8/12/2021JPMorgan Chase & Co.60,315$294K0.0%+264.4%0.285% 8/12/2021Ergoteles LLC18,570$91K0.0%N/A0.088% 8/11/2021Great Lakes Advisors LLC17,895$87K0.0%N/A0.084% 8/11/2021 Bank of New York Mellon Corp16,843$83K0.0%-64.8%0.079% 5/19/2021Virtu Financial LLC10,471$53K0.0%-56.4%0.049% 5/18/2021Voloridge Investment Management LLC304,198$1.55M0.0%N/A1.436% 5/18/2021Morgan Stanley998,127$5.09M0.0%+111.0%4.711% 5/18/2021Redmile Group LLC694,918$3.54M0.0%-45.2%3.280% 5/17/2021Royal Bank of Canada15,173$76K0.0%+76.5%0.072% 5/17/2021Walleye Trading LLC41,254$210K0.0%+7.4%0.195% Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the May 1st funding window clos5/17/2021Walleye Capital LLC118,476$604K0.0%+17.5%0.559% 5/17/2021HRT Financial LP73,587$375K0.0%N/A0.347% 5/17/2021Nuveen Asset Management LLC17,565$90K0.0%-48.7%0.083% 5/17/20215AM Venture Management LLC619,157$3.16M0.6%-55.1%2.922% 5/17/2021Goldman Sachs Group Inc.73,107$373K0.0%N/A0.345% 5/14/2021Kennedy Capital Management Inc.52,415$267K0.0%N/A0.247% 5/14/2021FIL Ltd83,191$424K0.0%+17,267.6%0.393% 5/14/2021UBS Asset Management Americas Inc.22,700$116K0.0%N/A0.107% 5/13/2021Trexquant Investment LP25,361$129K0.0%N/A0.120% 5/13/2021 SG Americas Securities LLC655,888$3.35M0.0%+2,725.9%3.096% 5/13/2021 Bank of New York Mellon Corp47,783$244K0.0%+57.5%0.226% 5/12/2021Northern Trust Corp105,719$539K0.0%-6.8%0.499% 5/12/2021Geode Capital Management LLC161,147$821K0.0%+9.1%0.761% 5/12/2021JPMorgan Chase & Co.16,550$85K0.0%+380.3%0.078% 5/7/2021BlackRock Inc.810,852$4.14M0.0%-2.1%3.827% 5/7/2021Versant Venture Management LLC1,259,662$6.42M1.3%-11.7%5.945% 5/3/2021Zurcher Kantonalbank Zurich Cantonalbank8,254$42K0.0%N/A0.039% (Data available from 1/1/2016 forward) APRE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of APRE shares? During the previous two years, the following institutional investors and hedge funds held shares of Aprea Therapeutics shares: AIGH Capital Management LLC ($1.53M), Sio Capital Management LLC ($1.24M), Stonepine Capital Management LLC ($491K), Landscape Capital Management L.L.C. ($116K), LPL Financial LLC ($53K), and Dimensional Fund Advisors LP ($45K), and BNP Paribas Financial Markets ($43K).Learn more on APRE's institutional investors. What percentage of Aprea Therapeutics stock is owned by institutional investors? 34.19% of Aprea Therapeutics stock is owned by institutional investors. Learn more on APRE's institutional investor holdings. Which institutional investors have been buying Aprea Therapeutics stock? The following institutional investors have purchased Aprea Therapeutics stock in the last 24 months: AIGH Capital Management LLC ($345K), Sio Capital Management LLC ($280K), Stonepine Capital Management LLC ($149.22K), Landscape Capital Management L.L.C. ($35.33K), LPL Financial LLC ($16.05K), BNP Paribas Financial Markets ($13.01K), and Dimensional Fund Advisors LP ($11.07K). How much institutional buying is happening at Aprea Therapeutics? Institutional investors have bought a total of 849,683 shares in the last 24 months. This purchase volume represents approximately $3.63M in transactions. Related Companies OSTX Institutional Ownership NRXP Institutional Ownership SRZN Institutional Ownership ATHE Institutional Ownership CVKD Institutional Ownership PLUR Institutional Ownership MRNS Institutional Ownership KZR Institutional Ownership ALXO Institutional Ownership ESLA Institutional Ownership This page (NASDAQ:APRE) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredMassive red flag about American consumerWhy is the U.S. Dollar suddenly crashing? Pundits on either side of the aisle have been warning that the U....Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aprea Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aprea Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy APRE Stock Free APRE Stock Alerts